Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
ProShares Ultra Health Care (RXL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: RXL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type ETF | Historic Profit 1.78% | Avg. Invested days 57 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | ETF Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Volume (30-day avg) - | Beta 1.08 | 52 Weeks Range 36.32 - 57.93 | Updated Date 06/29/2025 |
52 Weeks Range 36.32 - 57.93 | Updated Date 06/29/2025 |
Upturn AI SWOT
ProShares Ultra Health Care
ETF Overview
Overview
ProShares Ultra Health Care (RXO) seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health Care Index. It provides leveraged exposure to the U.S. healthcare sector.
Reputation and Reliability
ProShares is a well-established issuer known for its leveraged and inverse ETFs.
Management Expertise
ProShares has considerable experience in managing leveraged ETFs, requiring sophisticated understanding of market dynamics and risk management.
Investment Objective
Goal
To seek daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health Care Index.
Investment Approach and Strategy
Strategy: The ETF employs a leveraged strategy, aiming to provide twice the daily returns of its benchmark index.
Composition Primarily composed of financial instruments (derivatives) designed to magnify the returns of healthcare sector stocks.
Market Position
Market Share: RXO holds a niche market share within the leveraged healthcare ETF segment.
Total Net Assets (AUM): 60040000
Competitors
Key Competitors
- XLV
- VHT
- IHI
Competitive Landscape
The ETF industry in the healthcare sector is highly competitive, ProShares Ultra Health Care's ETF is relatively small. RXO offers leveraged exposure, differentiating it from non-leveraged ETFs like XLV and VHT. RXO has high risks and rewards compared to non-leveraged ETFs due to its strategy.
Financial Performance
Historical Performance: Historical performance can be highly volatile due to the leveraged nature of the ETF. Past performance is not indicative of future results. Please see fund details for current year to date performance.
Benchmark Comparison: The ETF aims to achieve two times the *daily* performance of the Dow Jones U.S. Health Care Index. Over longer periods, tracking error and volatility can significantly impact the ETF's performance relative to a simple 2x multiple of the index's returns.
Expense Ratio: 0.95
Liquidity
Average Trading Volume
The ETF exhibits moderate average trading volume compared to broader healthcare ETFs.
Bid-Ask Spread
The bid-ask spread may vary depending on market conditions, but it will be relatively wide.
Market Dynamics
Market Environment Factors
Economic conditions, healthcare policy changes, pharmaceutical innovation, and overall market sentiment influence the ETF's performance.
Growth Trajectory
RXO growth is highly influenced by the underlying index and use of leverage and its growth is dependent on healthcare sector performance and investor appetite for risk.
Moat and Competitive Advantages
Competitive Edge
RXO's competitive advantage lies in its leveraged exposure to the U.S. healthcare sector, catering to investors seeking amplified daily returns. Unlike standard healthcare ETFs, RXO provides a tool for short-term tactical plays based on anticipated healthcare sector movements. However, the leveraged structure also introduces higher risks compared to non-leveraged ETFs. Thus, RXO offers a unique proposition, targeting sophisticated investors with a high-risk tolerance and short-term investment horizon.
Risk Analysis
Volatility
Highly volatile due to its leveraged nature, RXO is subject to amplified price swings.
Market Risk
Specific risks include healthcare sector-related risks, such as regulatory changes, drug pricing pressures, and patent expirations. Additional risks exist due to its leveraged nature, which can lead to significant losses.
Investor Profile
Ideal Investor Profile
Sophisticated investors with a high-risk tolerance and a short-term investment horizon, seeking to capitalize on short-term movements in the healthcare sector.
Market Risk
Best suited for active traders seeking short-term tactical exposure and not for long-term investors or passive index followers.
Summary
ProShares Ultra Health Care (RXO) offers leveraged exposure to the U.S. healthcare sector, targeting sophisticated investors seeking amplified daily returns. Due to its leveraged nature, the ETF carries significant risks and is best suited for short-term tactical trading. The ETF's performance is highly dependent on the healthcare sector's movements and the effectiveness of its leveraged strategy. Investors should carefully consider their risk tolerance and investment horizon before investing in RXO.
Peer Comparison
Sources and Disclaimers
Data Sources:
- ProShares website
- ETF.com
- Morningstar
- YCharts
Disclaimers:
The data and analysis provided are for informational purposes only and do not constitute investment advice. Past performance is not indicative of future results. Investing in leveraged ETFs involves significant risks, including the potential for substantial losses.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ProShares Ultra Health Care
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.